You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ELIGLUSTAT TARTRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Eliglustat Tartrate

A generic version of ELIGLUSTAT TARTRATE was approved as eliglustat tartrate by AIZANT on September 8th, 2021.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ELIGLUSTAT TARTRATE?
  • What are the global sales for ELIGLUSTAT TARTRATE?
  • What is Average Wholesale Price for ELIGLUSTAT TARTRATE?
Drug patent expirations by year for ELIGLUSTAT TARTRATE
Recent Clinical Trials for ELIGLUSTAT TARTRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
SanofiPhase 1
Genzyme, a Sanofi CompanyPhase 1
Genzyme, a Sanofi CompanyPhase 3

See all ELIGLUSTAT TARTRATE clinical trials

Paragraph IV (Patent) Challenges for ELIGLUSTAT TARTRATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CERDELGA Capsules eliglustat tartrate 84 mg 205494 6 2018-08-20

US Patents and Regulatory Information for ELIGLUSTAT TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aizant ELIGLUSTAT TARTRATE eliglustat tartrate CAPSULE;ORAL 212463-001 Sep 8, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa Inc ELIGLUSTAT TARTRATE eliglustat tartrate CAPSULE;ORAL 212474-001 Dec 27, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex ELIGLUSTAT TARTRATE eliglustat tartrate CAPSULE;ORAL 212425-001 Jul 10, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys ELIGLUSTAT TARTRATE eliglustat tartrate CAPSULE;ORAL 212449-001 Aug 17, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Upsher Smith Labs ELIGLUSTAT TARTRATE eliglustat tartrate CAPSULE;ORAL 212420-001 May 2, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.